Finished
Rectal Surgery Evaluation Trial (RESET)
NCT03574493 · Institut du Cancer de Montpellier - Val d'Aurelle · Updated 12 Feb 2025
- What is being tested
- TME with LAR
- For
- Rectal Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 1,098 people. The full rules are on the registry page.
- Where
- France
- When
- Starts or started 16 Oct 2018, ends 31 Dec 2024. Registered 2 July 2018.
- Results
- None posted yet.
In the researchers' words
Total mesorectal excision (TME) is the standard of care for rectal cancer, which can be combined with low anterior resection (LAR) in patients with mid-to-low rectal cancer. The narrow pelvic space and difficulties in obtaining adequate exposure make surgeries technically challenging. Four techniques are used to perform the surgery: open laparotomy, laparoscopy, robot-assisted surgery, and transanal surgery. Comparative data for these techniques is required to provide clinical data on the surgical management of rectal cancers by surgery.
Sites
- Centre Regional de Lutte Contre le Cancer - Centre Val d'AurelleMontpellier, France